{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:43:24Z","timestamp":1790516604438,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,3,2]],"date-time":"2004-03-02T00:00:00Z","timestamp":1078185600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/1471-2334-4-7","type":"journal-article","created":{"date-parts":[[2004,3,9]],"date-time":"2004-03-09T02:23:46Z","timestamp":1078799026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Exacerbated inflammatory cellular immune response characteristics of HAM\/TSP is observed in a large proportion of HTLV-I asymptomatic carriers"],"prefix":"10.1186","volume":"4","author":[{"given":"Silvane Braga","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lia Fonseca","family":"Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Luiz","family":"Muniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lia Ribeiro","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elza","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailton","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walderez O","family":"Dutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J","family":"Gollob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar M","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,3,2]]},"reference":[{"key":"92_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1046\/j.1537-2995.1997.37297203532.x","volume":"37","author":"B Galvao-Castro","year":"1997","unstructured":"Galvao-Castro B, Loures L, Rodriques LG, Sereno A, Ferreira Junior OC, Franco LG, Muller M, Sampaio DA, Santana A, Passos LM, et al: Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion. 1997, 37: 242-243. 10.1046\/j.1537-2995.1997.37297203532.x.","journal-title":"Transfusion"},{"key":"92_CR2","first-page":"959","volume":"6","author":"ED Moreira Jr","year":"1993","unstructured":"Moreira ED, Ribeiro TT, Swanson P, Sampaio Filho C, Melo A, Brites C, Badaro R, Toedter G, Lee H, Harrington W: Seroepidemiology of human T-cell lymphotropic virus type I\/II in northeastern Brazil. J Acquir Immune Defic Syndr. 1993, 6: 959-963.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"92_CR3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H: Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977, 50: 481-492.","journal-title":"Blood"},{"key":"92_CR4","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980, 77: 7415-7419.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"92_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985, 2: 407-410. 10.1016\/S0140-6736(85)92734-5.","journal-title":"Lancet"},{"key":"92_CR6","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M: HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986, 1: 1031-1032. 10.1016\/S0140-6736(86)91298-5.","journal-title":"Lancet"},{"key":"92_CR7","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/00126334-199005000-00009","volume":"3","author":"H Prince","year":"1990","unstructured":"Prince H, Kleinman S, Doyle M, Lee H, Swanson P: Spontaneous lymphocyte proliferation in vitro characterizes both HTLV-I and HTLV-II infection. J Acquir Immune Defic Syndr. 1990, 3: 1199-1200.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"92_CR8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4049\/jimmunol.161.1.482","volume":"161","author":"R Kubota","year":"1998","unstructured":"Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S: Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy\/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol. 1998, 161: 482-488.","journal-title":"J Immunol"},{"key":"92_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0022-510X(90)90217-B","volume":"97","author":"N Nishimoto","year":"1990","unstructured":"Nishimoto N, Yoshizaki K, Eiraku N, Machigashira K, Tagoh H, Ogata A, Kuritani T, Osame M, Kishimoto T: Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Neurol Sci. 1990, 97: 183-193. 10.1016\/0022-510X(90)90217-B.","journal-title":"J Neurol Sci"},{"key":"92_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/13550280260422668","volume":"8","author":"M Osame","year":"2002","unstructured":"Osame M: Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM\/TSP). J Neurovirol. 2002, 8: 359-364. 10.1080\/13550280260422668.","journal-title":"J Neurovirol"},{"key":"92_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ana.410270209","volume":"27","author":"S Jacobson","year":"1990","unstructured":"Jacobson S, Gupta A, Mattson D, Mingioli E, McFarlin DE: Immunological studies in tropical spastic paraparesis. Ann Neurol. 1990, 27: 149-156.","journal-title":"Ann Neurol"},{"key":"92_CR12","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1097\/00042560-199600001-00017","volume":"13","author":"S Jacobson","year":"1996","unstructured":"Jacobson S: Cellular immune responses to HTLV-I: immunopathogenic role in HTLV-I-associated neurologic disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1996, 13: S100-106.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"92_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/00042560-199909010-00012","volume":"22","author":"GP Taylor","year":"1999","unstructured":"Taylor GP, Tosswill JH, Matutes E, Daenke S, Hall S, Bain BJ, Davis R, Thomas D, Rossor M, Bangham CR, et al: Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr. 1999, 22: 92-100.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"92_CR14","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","volume":"46","author":"S Izumo","year":"1996","unstructured":"Izumo S, Goto I, Itoyama Y, Okajima T, Watanabe S, Kuroda Y, Araki S, Mori M, Nagataki S, Matsukura S, et al: Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology. 1996, 46: 1016-1021.","journal-title":"Neurology"},{"key":"92_CR15","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983, 33: 1444-1452.","journal-title":"Neurology"},{"key":"92_CR16","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/oxfordjournals.aje.a117580","volume":"142","author":"A Kramer","year":"1995","unstructured":"Kramer A, Maloney EM, Morgan OS, Rodgers-Johnson P, Manns A, Murphy EL, Larsen S, Cranston B, Murphy J, Benichou J, et al: Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Jamaica. Am J Epidemiol. 1995, 142: 1212-1220.","journal-title":"Am J Epidemiol"},{"key":"92_CR17","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, et al: Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol. 1998, 4: 586-593.","journal-title":"J Neurovirol"},{"key":"92_CR18","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood.V95.4.1386.004k22_1386_1392","volume":"95","author":"E Hanon","year":"2000","unstructured":"Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y, Usuku K, Osame M, Weber JN, Bangham CR: Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood. 2000, 95: 1386-1392.","journal-title":"Blood"},{"key":"92_CR19","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1089\/08892220050193209","volume":"16","author":"N Azimi","year":"2000","unstructured":"Azimi N, Mariner J, Jacobson S, A WT: How Does Interleukin 15 Contribute to the Pathogenesis of HTLV Type 1 \u2013 Associated Myelopathy\/Tropical Spastic paraparesis?. AIDS Research and Human Retroviruses. 2000, 16: 1717-1722. 10.1089\/08892220050193209.","journal-title":"AIDS Research and Human Retroviruses"},{"key":"92_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0165-5728(99)00175-7","volume":"102","author":"R Kubota","year":"2000","unstructured":"Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S: HTLV-I specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals. J Neuroimmunol. 2000, 102: 208-215. 10.1016\/S0165-5728(99)00175-7.","journal-title":"J Neuroimmunol"},{"key":"92_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/00019052-200106000-00019","volume":"14","author":"M Nagai","year":"2001","unstructured":"Nagai M, Jacobson S: Immunopathogenesis of human T cell lymphotropic virus type I-associated myelopathy. Curr Opin Neurol. 2001, 14: 381-386. 10.1097\/00019052-200106000-00019.","journal-title":"Curr Opin Neurol"},{"key":"92_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00126334-200105010-00001","volume":"27","author":"EM Carvalho","year":"2001","unstructured":"Carvalho EM, Bacellar O, Porto AF, Braga S, Galvao-Castro B, Neva F: Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors. J Acquir Immune Defic Syndr. 2001, 27: 1-6.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"92_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/00005072-199401000-00009","volume":"53","author":"F Umehara","year":"1994","unstructured":"Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M: Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1994, 53: 72-77.","journal-title":"J Neuropathol Exp Neurol"},{"key":"92_CR24","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.159.4.2018","volume":"159","author":"WE Biddison","year":"1997","unstructured":"Biddison WE, Kubota R, Kawanishi T, Taub DD, Cruikshank WW, Center DM, Connor EW, Utz U, Jacobson S: Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol. 1997, 159: 2018-2025.","journal-title":"J Immunol"},{"key":"92_CR25","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1128\/jvi.64.11.5682-5687.1990","volume":"64","author":"JH Richardson","year":"1990","unstructured":"Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG: In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol. 1990, 64: 5682-5687.","journal-title":"J Virol"},{"key":"92_CR26","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.1073\/pnas.80.17.5402","volume":"80","author":"M Popovic","year":"1983","unstructured":"Popovic M, Lange-Wantzin G, Sarin PS, Mann D, Gallo RC: Transformation of human umbilical cord blood T cells by human T-cell leukemia\/lymphoma virus. Proc Natl Acad Sci U S A. 1983, 80: 5402-5406.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"92_CR27","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1182\/blood.V98.5.1506","volume":"98","author":"JA Sakai","year":"2001","unstructured":"Sakai JA, Nagai M, Brennan MB, Mora CA, Jacobson S: In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: predominant expansion of CD8+ T cells. Blood. 2001, 98: 1506-1511. 10.1182\/blood.V98.5.1506.","journal-title":"Blood"},{"issue":"4","key":"92_CR28","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.4049\/jimmunol.150.4.1147","volume":"150","author":"M Azuma","year":"1993","unstructured":"Azuma M, Phillips JH, LL L: CD28- T lymphocytes. Antigenic and functional properties. J Immunol. 1993, 150 (4): 1147-1159.","journal-title":"J Immunol"},{"issue":"3","key":"92_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1046\/j.1365-2567.1999.00901.x","volume":"98","author":"MP Weekes","year":"1999","unstructured":"Weekes MP, Wills MR, Mynard K, Hicks R, Sissins JG, AJ C: Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD28- CD8+ T-cell population. Immunology. 1999, 98 (3): 443-449. 10.1046\/j.1365-2567.1999.00901.x.","journal-title":"Immunology"},{"issue":"5","key":"92_CR30","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.4049\/jimmunol.169.5.2762","volume":"169","author":"JF Giguere","year":"2002","unstructured":"Giguere JF, Paquette JS, Bounou S, Cantin R, MJ T: New insight into the functionality of a virion-anchored host cell membrane protein: CD28 versus HIV type 1. J Immunol. 2002, 169 (5): 2762-2771.","journal-title":"J Immunol"},{"key":"92_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1046\/j.1365-3083.1996.d01-9.x","volume":"43","author":"WO Dutra","year":"1996","unstructured":"Dutra WO, Martins-Filho OA, Cancado JR, Pinto-Dias JC, Brener Z, Gazzinelli G, Carvalho JF, Colley DG: Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol. 1996, 43: 88-93. 10.1046\/j.1365-3083.1996.d01-9.x.","journal-title":"Scand J Immunol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-4-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-4-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-4-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-4-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T11:58:54Z","timestamp":1726228734000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-4-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,2]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,12]]}},"alternative-id":["92"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-4-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,2]]},"assertion":[{"value":"7 October 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}